Office of the Assistant Secretary for Preparedness and Response. (2021). Casirivimab/Imdevimab. (Added 1/22/2021.) U.S. Department of Health and Human Services.
This page discusses the Casirivimab/Imdevimab allocation and distribution process, the Emergency Use Authorization (EUA) process, and links to additional documents related to the EUA of Casirivimab/Imdevimab.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.